基于机制的双特异抗体的药理动力学和药理动力学建模:挑战和机遇
Jin Niu1, Weirong Wang1, Daniele Ouellet1
1Clinical Pharmacology and Pharmacometrics, Janssen Research & Development, Spring House, PA, USA.
Expert review of clinical pharmacology
|September 25, 2023
概括
基于机制的药理动力学/药理动力学 (PK/PD) 建模对于优化双特异抗体 (bsAb) 开发至关重要. 这些模型有助于理解bsAb行为,预测结果,并为药物开发策略提供信息.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
- 药物开发 药物开发
背景情况:
- 双特异性抗体 (bsAbs) 是一种能够识别两个不同的抗原的工程分子.
- 在治疗领域,bsAbs的发展带来了独特的挑战.
- 基于机制的药理动力学/药理动力学 (PK/PD) 建模对于bsAb优化至关重要.
研究的目的:
- 在bsAb开发中介绍PK/PD模型应用的指导原则和案例.
- 为了说明PK/PD模型如何解决BSAb开发中的常见问题.
- 讨论挑战,知识差距,以及在bsAbs中PK/PD建模的未来方向.
主要方法:
- 适合目的,基于机制的PK/PD模型的应用.
- bsAbs.的主要药理元素的表征.
- 对模型的推断,以根据MOA和临床数据预测治疗结果.
主要成果:
- PK/PD模型为基于模型的bsAb药物开发提供了强大的工具.
- 模型区分系统和药物特定的参数来预测结果.
- 在开发过程中的学习和确认周期中成功应用PK/PD建模辅助.
结论:
- 基于机制的 PK/PD 建模对于推动 bsAb 开发至关重要.
- 对于新的bsAb设计和MoAs.As,模型的持续调整是必要的.
- PK/PD建模为基于模型的药物开发提供了持续的机会.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
96
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
96
Mechanistic Models: Overview of Compartment Models
104
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
104
Pharmacokinetic Models: Overview
761
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
761
Physiological Pharmacokinetic Models: Assumption with Protein Binding
63
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
63
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
89
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
89
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61


